Dataset of DNA methylation profiles of 189 pediatric central nervous system, soft tissue, and bone tumors.

Epigenetics Pediatric oncology Precision medicine Targeted methylation sequencing

Journal

Data in brief
ISSN: 2352-3409
Titre abrégé: Data Brief
Pays: Netherlands
ID NLM: 101654995

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 10 04 2024
revised: 26 05 2024
accepted: 30 05 2024
medline: 8 7 2024
pubmed: 8 7 2024
entrez: 8 7 2024
Statut: epublish

Résumé

Alterations in DNA methylation profiles belong to important mechanisms in cancer development, and their assessment can be utilized for rapid and precise diagnostics. Therefore, establishing datasets of methylation profiles can improve and deepen our understanding of the role of epigenetic changes in cancer development as well as improve our diagnostic capabilities. In this dataset, we generated NGS data for 189 samples of pediatric CNS, soft tissue, and bone tumors. The sequencing libraries were prepared using methyl capture bisulfite sequencing, an effective compromise between whole-genome bisulfite sequencing and array-based methods with a more limited scope of target regions. The larger part of the cohort was processed with the Agilent SureSelectXT Human Methyl-Seq kit (149 samples) and the rest with the Illumina TruSeq Methyl Capture EPIC Library Prep Kit (40 samples). The data presented in this article may help other researchers further elucidate the importance of methylation in diagnosing pediatric CNS tumors, soft tissue, and bone tumors.

Identifiants

pubmed: 38974008
doi: 10.1016/j.dib.2024.110590
pii: S2352-3409(24)00557-2
pmc: PMC11226799
doi:

Types de publication

Journal Article

Langues

eng

Pagination

110590

Informations de copyright

© 2024 The Authors.

Auteurs

Robin Jugas (R)

Department of Biology, Faculty of Medicine and Central European Institute of Technology, Masaryk University, Kamenice 753/5, 625 00 Brno, Czechia.

Petra Pokorna (P)

Department of Biology, Faculty of Medicine and Central European Institute of Technology, Masaryk University, Kamenice 753/5, 625 00 Brno, Czechia.
Department of Biochemistry, Faculty of Science, Masaryk University, Kamenice 753/5, 625 00 Brno, Czechia.

Sona Adamcova (S)

Department of Biology, Faculty of Medicine and Central European Institute of Technology, Masaryk University, Kamenice 753/5, 625 00 Brno, Czechia.

Katerina Kozelkova (K)

Department of Biology, Faculty of Medicine and Central European Institute of Technology, Masaryk University, Kamenice 753/5, 625 00 Brno, Czechia.

Dana Knoflickova (D)

Department of Biology, Faculty of Medicine and Central European Institute of Technology, Masaryk University, Kamenice 753/5, 625 00 Brno, Czechia.
Department of Oncological Pathology, Masaryk Memorial Cancer Institute, Žlutý kopec 543/7, 656 53 Brno, Czechia.

Hana Palova (H)

Department of Biology, Faculty of Medicine and Central European Institute of Technology, Masaryk University, Kamenice 753/5, 625 00 Brno, Czechia.

Jaroslav Sterba (J)

Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavská 20, 625 00 Brno, Czechia.

Ondrej Slaby (O)

Department of Biology, Faculty of Medicine and Central European Institute of Technology, Masaryk University, Kamenice 753/5, 625 00 Brno, Czechia.

Classifications MeSH